Global X - Genomics and Biotechnology ETF (GNOM) |
| 49.6825 0.17 (0.34%) 05-29 16:00 |
| Open: | 49.41 |
| High: | 49.915 |
| Low: | 49.41 |
| Volume: | 66,671 |
| Market Cap: | 56(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 58.30 |
| Resistance 1: | 49.92 |
| Pivot price: | 46.40 |
| Support 1: | 46.04 |
| Support 2: | 43.65 |
| 52w High: | 51.42 |
| 52w Low: | 31.04 |
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 24 May 2026
(GNOM) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Wed, 13 May 2026
(GNOM) Risk Channels and Responsive Allocation - Stock Traders Daily
Mon, 11 May 2026
Best CRISPR Gene Editing ETFs for 2026 and How to Invest - The Motley Fool
Tue, 17 Mar 2026
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - Yahoo Finance
Mon, 16 Mar 2026
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Wed, 11 Feb 2026
7 Best Biotech ETFs to Buy Now | Investing - U.S. News Money
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
